Contact
QR code for the current URL

Story Box-ID: 1119045

EvidentIQ Group GmbH Rathausmarkt 5 20095 Hamburg, Germany https://evidentiq.com
Contact Mr Andreas Weber

EvidentIQ welcomes DACIMA Software into their end-to-end eClinical solutions group.

This merger will strengthen their portfolio and help bring EvidentIQ’s offer to yet another level of expertise.

(PresseBox) (Hamburg, Germany, )
Today, EvidentIQ, a leading provider of end-to-end eClinical and Patient Insights solutions, announced the acquisition of DACIMA Software, a Canadian clinical software company founded in 2006.

EvidentIQ, based in Hamburg, is a leading clinical data science group, offering an end-to-end platform of state-of-the art eClinical solutions (eConsent, EDC, CTMS, eCOA,) that helps its customers with the planning and execution of both hybrid/decentralized and traditional clinical trials. Thanks to its global patient platform Carenity, the group combines their technology with a direct access to real-world patient insights, enabling them to support sponsors and CROs with innovative offerings such as eFeasibility, eRecruitment and Real-World Evidence data collection and analysis

Dacima, based in Montreal, offers a cutting edge flexible Electronic Data Capture (EDC) platform for the design and management of clinical trials, observational studies, patient registries, clinical databases, electronic Patient Reported Outcomes (ePRO), eDiaries and eConsent. It’s advanced eClinical capabilities will enrich EvidentIQ Group product lineup with software solutions for electronic Clinical Outcome Assessment (eCOA) and eConsent.  The company has been founded by experts in epidemiology, medical research and information technology who understand the needs of users and requirements of eClinical software for the healthcare sector.

By integrating EvidentIQ’s patient community, data science solutions and eClinical backbone with Dacima’s products, the group will provide the technology for hybrid and decentralized clinical trials (DCT) as a one-stop-shop on a global basis. This acquisition will help EvidentIQ to build a complete offer that covers every step in the value chain of clinical research and development, enhance their unique end-to-end solutions to help the life sciences industry run innovative patient-centric clinical studies and optimize clinical research.

EvidentIQ Group GmbH

EvidentIQ is a next generation technology-amplified data science group championing new standards in value creation and innovation driven relevance for customers. The EvidentIQ offering brings a pioneering end-to-end eClinical solution that meets increasing customer demand across clinical operations and clinical data management needs, with a suite of applications within a single integrated cloud platform. By combining its platform with a broad data science service portfolio including patient recruitment, patient engagement media and RWE solutions, EvidentIQ significantly aids customers in optimizing HTA submissions, pricing and reimbursement needs. EvidentIQ has become a pillar of Real-World Evidence and data science pioneering in digitalization of clinical research and offering state-of-the art eClinical solutions (eConsent, EDC, CTMS, eCOA).

EvidentIQ supports 15 of the top 20 pharma companies through novel RWE solutions and 150+ SMB customers in over 20 countries, including the US, Germany, France, the UK, Italy, Japan and China.

The publisher indicated in each case (see company info by clicking on image/title or company info in the right-hand column) is solely responsible for the stories above, the event or job offer shown and for the image and audio material displayed. As a rule, the publisher is also the author of the texts and the attached image, audio and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.
Important note:

Systematic data storage as well as the use of even parts of this database are only permitted with the written consent of unn | UNITED NEWS NETWORK GmbH.

unn | UNITED NEWS NETWORK GmbH 2002–2024, All rights reserved

The publisher indicated in each case (see company info by clicking on image/title or company info in the right-hand column) is solely responsible for the stories above, the event or job offer shown and for the image and audio material displayed. As a rule, the publisher is also the author of the texts and the attached image, audio and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.